Supplemental Figure S1. MV score ROC cutoffs and Kaplan-Meier survival curves for distant metastasis-free survival, split by treatment subgroups from An Endothelial Gene Signature Score Predicts Poor Outcome in Patients with Endocrine-Treated, Low Genomic Grade Breast Tumors

(A) ROC and (B) Kaplan-Meier analysis of our training dataset in patient subgroups (i) All, (ii) Untreated, (iii) Untreated ER positive and (iv) Endocrine treated patients.